Literature DB >> 10397749

The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain.

M J van Vugt1, M J Kleijmeer, T Keler, I Zeelenberg, M A van Dijk, J H Leusen, H J Geuze, J G van de Winkel.   

Abstract

Within multi-subunit Ig receptors, the FcR gamma-chain immunoreceptor tyrosine-based activation motif (ITAM) plays a crucial role in enabling antigen presentation. This process involves antigen-capture and targeting to specific degradation and major histocompatibility complex (MHC) class II loading compartments. Antigenic epitopes are then presented by MHC class II molecules to specific T cells. The high-affinity receptor for IgG, hFcgammaRIa, is exclusively expressed on myeloid lineage cells and depends on the FcR gamma-chain for surface expression, efficient ligand binding, and most phagocytic effector functions. However, we show in this report, using the IIA1.6 cell model, that hFcgammaRIa can potentiate MHC class II antigen presentation, independently of a functional FcR gamma-chain ITAM. Immunoelectron microscopic analyses documented hFcgammaRIa alpha-chain/rabbit IgG-Ovalbumin complexes to be internalized and to migrate via sorting endosomes to MHC class II-containing late endosomes. Radical deletion of the hFcgammaRIa alpha-chain cytoplasmic tail did not affect internalization of rabbit IgG-Ovalbumin complexes. Importantly, however, this resulted in diversion of receptor-ligand complexes to the recycling pathway and decreased antigen presentation. These results show the hFcgammaRIa cytoplasmic tail to contain autonomous targeting information for intracellular trafficking of receptor-antigen complexes, although deficient in canonical tyrosine- or dileucine-targeting motifs. This is the first documentation of autonomous targeting by a member of the multichain FcR family that may critically impact the immunoregulatory role proposed for hFcgammaRIa (CD64).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397749

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Serine phosphorylation of FcγRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G.

Authors:  Andrew W Gibson; Xinrui Li; Jianming Wu; Julie G Baskin; Chander Raman; Jeffrey C Edberg; Robert P Kimberly
Journal:  J Leukoc Biol       Date:  2011-10-14       Impact factor: 4.962

2.  Molecular cloning and expression of the porcine high-affinity immunoglobulin G Fc receptor (FcgammaRI).

Authors:  Gaiping Zhang; Songlin Qiao; Qingmei Li; Xuannian Wang; Yanhua Duan; Li Wang; Zhijun Xiao; Chun Xia
Journal:  Immunogenetics       Date:  2006-08-16       Impact factor: 2.846

3.  C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).

Authors:  Katherine B Bodman-Smith; Alirio J Melendez; Ian Campbell; Patrick T Harrison; Janet M Allen; John G Raynes
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

4.  Expression of Fc Fragment Receptors of Immunoglobulin G (FcγRs) in Rat Hepatic Stellate Cells.

Authors:  Hong Shen; Manna Zhang; Kelly Kaita; Gerald Y Minuk; Julia Rempel; Yuewen Gong
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

5.  Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO.

Authors:  S A Rebuffat; M Morin; B Nguyen; F Castex; B Robert; S Péraldi-Roux
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

Review 6.  Fc-receptors and immunity to malaria: from models to vaccines.

Authors:  R J Pleass
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

7.  Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody.

Authors:  H Marie Lacy; Melinda G Gunnell; Elizabeth M Laurenzana; S Michael Owens
Journal:  Int Immunopharmacol       Date:  2007-10-23       Impact factor: 4.932

8.  Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity.

Authors:  Jeffrey M Beekman; Jantine E Bakema; Jan G J van de Winkel; Jeanette H W Leusen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-30       Impact factor: 11.205

9.  B-cells get the T-cells but antibodies get the worms.

Authors:  Richard J Pleass; Jerzy M Behnke
Journal:  Trends Parasitol       Date:  2009-09-04

10.  Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion.

Authors:  Xinrui Li; Kaihong Su; Chuanyi Ji; Alexander J Szalai; Jianming Wu; Yan Zhang; Tong Zhou; Robert P Kimberly; Jeffrey C Edberg
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.